Truvian Sciences Raises More Than $105M in Series C Financing

– Truvian Sciences, a San Diego, CA-based closed more than $105m in a Series C financing.
– The round was led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures.
– The company intends to use the funds to advance development of its automated benchtop blood testing system, paving the way to submit the device for U.S. Food and Drug Administration (FDA) clearance, and to scale its team in preparation for broad commercialization.
– Truvian is a healthcare company at the intersection of diagnostics and consumer technology.